首页> 外文期刊>International Journal of Pharmacy and Pharmaceutical Sciences >EVALUATION OF SAFETY PROFILES OF ANURADHA OIL-AN HERBAL WOUND HEALING FORMULATION IN LABORATORY ANIMALS
【24h】

EVALUATION OF SAFETY PROFILES OF ANURADHA OIL-AN HERBAL WOUND HEALING FORMULATION IN LABORATORY ANIMALS

机译:实验室动物菊苣油-中草药伤口愈合配方的安全性评价

获取原文
           

摘要

Objective: To investigate Acute, Sub-acute dermal toxicity, Mucus membrane irritation activity of Anuradha Oil’s (AO and AO11) – An herbal formulation having wound healing potential. Methods: The formulations were derived from Curcuma longa Linn and Glycyrrhiza glabra Linn rhizhomes, Hamiltonia suaveolens Roxb bark, Typha angustifolia Linn flowers, Azadirachta indica A. Juss leaves without/with pig fat (AO and AO11 respectively)mixed in certain proportion using Sesamum indicum Linn oil as a base, manufactured at a GMP certified facility. Acute, sub-acute dermal safety, mucus membrane irritation profiles were studied by OECD guidelines number 434, 410 and 405 in Wistar rats and New Zealand rabbits respectively. For acute study dermal application of 2000 mg/kg single dose and for sub-acute study limit dose protocol of 1000 mg/kg for 28 days was used. For mucus membrane irritation test 0.10 ml dose was used. Results: In an acute study no local reaction, behavioral changes and mortality was observed at 2000 mg/kg by dermal route till 14 days. In sub-acute study with dermal application of 1000 mg/kg for 28 days, there were no abnormal signs/symptoms at the application site, no difference in body weight, food consumption, hematology/enzyme profiles, urine analysis, relative organ weights and histopathological observations of vital organs in comparison to control animals. Mucus membrane of rabbits showed no evidence of irritation for both oils. Conclusion: Acute dermal LD50 cut off for AO and AO11was found to be>2000 mg/kg, safe for dermal application for 28 days using the dose of 1000 mg/kg and non-irritant. Keywords: Anuradha oil, Dermal toxicity, Acute/Sub acute safety, Mucus membrane irritation, Rats/ Rabbits.
机译:目的:研究具有伤口愈合潜力的草药制剂阿努拉达油(AO和AO11)的急性,亚急性皮肤毒性,粘膜刺激性。方法:这些配方分别来自姜黄和甘草,哈密尔顿油菜花,香蒲花,印A(Azadirachta indica A)。在无/有猪油(分别是AO和AO11)下混合的芝麻叶片用芝麻制成。亚麻油为基础,由GMP认证工厂生产。经合组织准则编号434、410和405分别在Wistar大鼠和新西兰兔中研究了急性,亚急性皮肤安全性,粘膜刺激性。对于2000 mg / kg单剂量的皮肤急性研究,以及对于28天1000 mg / kg的亚急性研究极限剂量方案,均应使用。对于粘液膜刺激试​​验,使用0.10ml剂量。结果:在一项急性研究中,经皮肤途径直至2000 d为止,在2000 mg / kg时未观察到局部反应,行为变化和死亡率。在以1000 mg / kg皮肤应用28天的亚急性研究中,应用部位没有异常体征/症状,体重,食物消耗,血液学/酶学特征,尿液分析,相对器官重量和与对照动物相比,重要器官的组织病理学观察。兔子的粘膜没有显示出两种油刺激的迹象。结论:AO和AO11的急性皮肤LD50截断值> 2000 mg / kg,使用1000 mg / kg的剂量对皮肤使用28天是安全的,无刺激性。关键词:Anuradha油,皮肤毒性,急性/亚急性安全,粘液膜刺激,大鼠/兔子。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号